Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $387,000 - $454,875
37,500 New
37,500 $435,000
Q1 2022

May 17, 2022

SELL
$9.81 - $15.4 $153,506 - $240,979
-15,648 Reduced 3.15%
481,424 $5.24 Million
Q4 2021

Feb 15, 2022

BUY
$12.09 - $14.68 $1.87 Million - $2.27 Million
154,500 Added 45.1%
497,072 $6.73 Million
Q3 2021

Nov 16, 2021

BUY
$13.25 - $15.13 $617,715 - $705,360
46,620 Added 15.75%
342,572 $4.64 Million
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $1.16 Million - $1.44 Million
89,252 Added 43.18%
295,952 $4.23 Million
Q1 2021

May 18, 2021

SELL
$13.59 - $18.54 $6.1 Million - $8.32 Million
-448,632 Reduced 68.46%
206,700 $2.89 Million
Q4 2020

Feb 17, 2021

BUY
$14.3 - $18.74 $9.37 Million - $12.3 Million
655,332 New
655,332 $12.3 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.9B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.